Procollagen II C-propeptide in joint fluid: Changes in concentration with age, time after knee injury, and osteoarthritis

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1765-1769

  Stefan Lohmander, L ^a   Yoshihara, Yasuo ^b   Roos, Harald ^a   Kobayashi, Tatsuo ^b   Yamada, Harumoto ^b   Shinmei, Masayuki ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

aggrecan; collagen C propeptide; collagen type II; osteoarthritis; synovial fluid

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; PROCOLLAGEN; PROCOLLAGEN II PROPEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KNEE INJURY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KNEE INJURIES; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; SYNOVIAL FLUID; TIME FACTORS;

EID: 10244234102     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lohmander LS, Dahlberg L, Ryd L, Heinegård D: Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 1989;32:1434-42.
2. Lohmander LS, Hoerrner LA, Lark MW: Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-9.
3. Lohmander LS, Hoerrner LA, Dahlberg L, Roos H, Björnsson S, Lark MW: Stromelysin, tissue inhibitor and proteoglycan fragments in human knee joint fluid after injury. J Rheumatol 1993;20:1362-8.
4. Lohmander LS, Roos H, Dahlberg L, Hoerrner LA, Lark MW: Temporal patterns of stromelysin, tissue inhibitor and proteoglycan fragments in synovial fluid after injury to knee cruciate ligament or meniscus. J Orthop Res 1994;12:21-8.
5. Lohmander LS, Saxne T, Heinegård D: Release of cartilage oligomeric matrix protein into joint fluid after injury and in osteoarthrosis. Ann Rheum Dis 1994;53:8-13.
6. Dahlberg L, Fridén T, Roos H, Lark MW, Hoerrner LA, Lohmander LS: Longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture - synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase. Br J Rheumatol 1994;33:1107-11.
7. Lohmander LS, Hoerrner LA, Lark MW: Increased concentrations of collagenase (MMP-1) in joint fluid after knee injury and in osteoarthritis (abstr). Trans Orthop Res Soc 1995;20:99.
8. Lohmander LS, Ionescu M, Poole AR: Changes in aggrecan structure and metabolism after knee injury and in osteoarthritis (abstr). Trans Orthop Res Soc 1995;20:412.
9. Lohmander LS, Saxne T, Heinegård D: Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis 1996; (in press).
10. Lohmander LS: Articular cartilage and osteoarthritis - The role of molecular markers to monitor breakdown, repair and disease. J Anat 1994;184-477-92.
11. Lohmander LS, Roos H: Knee ligament injury, surgery and osteoarthritis - Truth or Consequences? Acta Orthop Scand 1994;65:605-9.
12. Eyre DR, McDevitt CA, Billingham ME, Muir H: Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthritis. Biochem J 1980;188:823-37.
13. Aigner T, Stöss H, Weseloh G, Zeiler G, von der Mark K: Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol 1992;62:337-45.
14. Carney SL, Billingham MEJ, Muir H, Sandy JD: Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritis. J Orthop Res 1984;2:201-6.
15. Sandy JD, Adams ME, Billingham ME, Plaas A, Muir H: In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum 1984;27:388-97.
16. Uitto J, Allan RE, Polak KL: Conversion of type II procollagen to collagen. Eur J Biochem 1979;99:97-103.
17. Choi HU, Tang LH, Johnson TL, Pal S, Rosenberg LC: Isolation and characterization of a 35,000 molecular weight subunit fetal cartilage matrix protein. J Biol Chem 1983;258:655-61.
18. Peltonen L, Halila R, Ryhanen L: Enzymes converting procollagens to collagens. J Cell Biochem 1985;28:15-21.
19. van der Rest M, Rosenberg LC, Olsen BR, Poole AR: Chondrocalcin is identical with the C-propeptide of type II procollagen. Biochem J 1986;237:923-5.
20. Poole AR, Rizkalla G, Ionescu M, Rosenberg LC, Bogoch E: Increased content of the C-propeptide of type II collagen in osteoarthritic human articular cartilage (abstr). Trans Orthop Res Soc 1991;16:343.
21. Dodge GR, Poole AR: Immunohistochemical detection and immunochemical analysis of Type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989;83:647-61.
22. Hollander AP, Heathfield TF, Webber C, et al.: Increased damage to type II collagen in osteoarthritic cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
23. Shinmei M, Ito K, Matsuyama S, Yoshihara Y, Matsuzawa K: Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1993;1:121-8.
24. Shinmei M, Kobayashi T, Yoshihara Y, Samura A: Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid. J Rheumatol 1995;(suppl 43)22:78-81.
25. Lohmander LS, Shinmei M: Procollagen II C-propeptide in joint fluid - changes in concentration with age and time after injury (abstr). Trans Orthop Res Soc 1994;19:196.
26. Dahlberg L, Ryd L, Heinegård D, Lohmander LS: Proteoglycan fragments in joint fluid - influence of arthrosis and inflammation. Acta Orthop Scand 1992;63:417-23.
27. Dahlberg L, Roos H, Saxne T, et al.: Cartilage metabolism in the injured and uninjured knee of the same patient. Analysis of aggrecan fragments, cartilage matrix oligomeric protein, stromelysin, and TIMP in synovial fluid, and COMP in serum. Ann Rheum Dis 1994;53:23-7.
28. Shinmei M, Miyauchi S, Machida A, Miyazaki K: Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
29. Okada Y, Shinmei M, Tanaka O, et al.: Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-90.
30. Rizkalla G, Reiner A, Bogoch E, Poole AR: Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 1992;90:2268-77.
31. Nelson F, Reiner A, Ionescu M, Brooks E, Bogoch E, Poole AR: The content of the C-propeptide of type II collagen in articular cartilage is an index of synthesis of this molecule which is increased in osteoarthritis (abstr). Trans Orthop Res Soc 1994;19:216.
32. Alini M, Matsui Y, Dodge GR, Poole AR: The extracellular matrix of cartilage in the growth plate before and during calcification: Changes in composition and degradation of type II collagen. Calcif Tissue Int 1992;50:327-35.
33. Shinmei M, Masuda K, Kikuchi T, Shimomura Y: The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumatol 1989;(suppl 18)16:32-4.
34. Hardingham TE, Bayliss MT, Noble DP: Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Br J Rheumatol 1992;31:1-6.